Viewpoint
Zachary Hafner
In an age of consumerism and heightened attention to the whole patient across a broader continuum of care, organizations that support the availability of a broad set of sexual health services to a diverse group of consumers will have a big competitive advantage, but they may face challenges balancing the costs.

High-risk insurance pools might be making a comeback thanks to the seemingly imminent end of the ACA, but some experts wonder if this particular bridge to the future might come with a tol

Q&A
Interview by Peter Wehrwein
Journalist David France’s How to Survive A Plague is a searing firsthand account of the early years of the HIV/AIDS epidemic in New York City. AIDS activists, most of them gay men, were fighting for their lives. Researchers, politicians, public health officials, and pharma were slow to respond—or resisted outright.
News & Commentary
Fifty percent of patients admitted to intensive care units (ICUs) are either too well or too sick to derive any benefits from the costly care they would get, according to a research letter in the Dec. 27, 2016, issue of JAMA Internal Medicine.

Comes a new twist in the recent uproar about how pharmaceutical companies are spiking costs for variations of medicines that have been around for decades.

Sexual Health
Jan Greene
Women’s health advocates are concerned about health coverage guarantees that could disappear as Republicans in Congress and the White House go about dismantling Obamacare. These include everything from contraceptive coverage to breast cancer screenings to equity in the premiums women pay for insurance.

Officials at Harvard Pilgrim Health Care believe that they’ve responded to the soaring cost of drugs with tools already familiar to stakeholders: paying based on outcomes (for Enbrel), and paying based on value (for Forteo).

But that might change since the pharmaceutical industry itself is beginning to examine this disconnect, according to STAT.

Sexual Health
Robert Calandra
New York State’s Target Case Management (TCM) program was created in 1990 by to help people with mental health and substance abuse issues stay engaged in their care. It’s been very successful for people with HIV as well. Can it be expanded for other chronic conditions?
News & Commentary
Don’t discard the Cadillac tax even if other large chunks of the ACA are tossed, urges a joint report by two think tanks. Fixing some flaws in this excise tax, scheduled to take effect in 2020, will help control health care spending and provide revenue.
Viewpoint
Michael Schlosser, MD
;
Felix Lee, MD
There are some success stories. Lowe’s pioneering flat-rate deal with the Cleveland Clinic for heart surgery has shown both cost savings and quality improvement. Other large employers, notably Walmart and PepsiCo, have followed suit, signing contracts with self-described, single-hospital “centers of excellence” for a handful of elective procedures.